Literature DB >> 23731284

End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.

Saadia Sherazi1, Scott McNitt, Mehmet K Aktas, Bronislava Polonsky, Abrar H Shah, Arthur J Moss, James P Daubert, Wojciech Zareba.   

Abstract

BACKGROUND: Implantable cardioverter defibrillator (ICD)-delivered shocks can cause substantial distress, warranting consideration of ICD deactivation at end of life. This study was designed to describe the patterns of end-of-life management in patients with ICDs.
METHODS: There was a retrospective chart review of 98 patients who died in the ICD arm of multicenter automated defibrillator implantation trial II (MADIT II). The pattern of ICD management and the frequency of ICD shocks delivered before death were reviewed.
RESULTS: We identified three groups: Group 1 consisting of individuals who underwent ICD, deactivation, 15 (15%); Group 2 patients without ICD deactivation who were in hospice or with "do not resuscitate" (DNR) orders, 36 (37%); and Group 3 patients without ICD deactivation who were not in hospice care and did not have DNR orders, 47 (48%). Out of 15 deactivations, 11 (73%) occurred in the week before death. None of the patients in Group 1 received an ICD shock in the 24-hour period before death. However, one (3%) patient from Group 2 and nine (19%) patients from Group 3 had shocks during the 24 hours before death (P = 0.03). In the last week before death, three (20%), two (6%), and six (13%) patients received ICD shocks in the three groups, respectively (P = 0.28).
CONCLUSIONS: In patients with terminal conditions who are at risk for imminent death, active management of the patient's ICD, including timely discussions regarding ICD deactivation, may reduce the risk of ICD shocks during the end of life. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  end of life: ICD and deactivation

Mesh:

Year:  2013        PMID: 23731284     DOI: 10.1111/pace.12188

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  17 in total

Review 1.  Hospice in heart failure: why, when, and what then?

Authors:  Jeffrey L Spiess
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

2.  Management of Heart Failure in Patients Nearing the End of Life-There is So Much More To Do.

Authors:  Lisa LeMond; Sarah J Goodlin
Journal:  Card Fail Rev       Date:  2015-04

Review 3.  [ICD in elderly patients].

Authors:  Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-03

Review 4.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 5.  Complex Care Options for Patients With Advanced Heart Failure Approaching End of Life.

Authors:  Sara E Wordingham; Colleen K McIlvennan; J Nicholas Dionne-Odom; Keith M Swetz
Journal:  Curr Heart Fail Rep       Date:  2016-02

6.  Features and outcomes of patients who underwent cardiac device deactivation.

Authors:  Lillian C Buchhalter; Abigale L Ottenberg; Tracy L Webster; Keith M Swetz; David L Hayes; Paul S Mueller
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

7.  Implantable cardioverter defibrillators in octogenarians: clinical outcomes from a single center.

Authors:  D G Wilson; N Ahmed; R Nolan; A Frontera; G Thomas; E R Duncan
Journal:  Indian Pacing Electrophysiol J       Date:  2015-04-01

8.  Deactivation of implantable cardioverter-defibrillators.

Authors:  Darryl Wan; Santabhanu Chakrabarti
Journal:  CMAJ       Date:  2021-06-07       Impact factor: 8.262

9.  Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.

Authors:  Jane MacIver; Alana Tibbles; Filio Billia; Heather Ross
Journal:  SAGE Open Med       Date:  2016-04-07

10.  Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.

Authors:  Mei Ching Lee; Daniel P Sulmasy; Joseph Gallo; Joan Kub; Mark T Hughes; Stuart Russell; Anela Kellogg; Sharon G Owens; Peter Terry; Marie T Nolan
Journal:  Am J Hosp Palliat Care       Date:  2016-03-31       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.